CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-10 | Hollander David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2025-04-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2024-07-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +1,778 | 1,778 | ||
| 2023-09-29 | Hollander David Director | Grant or award · Stock Option (right to buy) | +0 | 5,000 | ||
| 2023-03-03 | Hollander David Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2022-02-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +4,000 | 4,000 | ||
| 2022-02-01 | Hollander David Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 |
Page 1 of 1 · 7 trades